Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.24 - $4.58 $2,808 - $53,586
11,700 Added 7.72%
163,200 $43,000
Q3 2022

Nov 14, 2022

SELL
$0.3 - $3.73 $34,860 - $433,426
-116,200 Reduced 43.41%
151,500 $56,000
Q2 2022

Aug 12, 2022

SELL
$0.26 - $0.46 $82,308 - $145,623
-316,572 Reduced 54.18%
267,700 $88,000
Q1 2022

May 13, 2022

SELL
$0.37 - $1.0 $179,349 - $484,728
-484,728 Reduced 45.34%
584,272 $257,000
Q4 2021

Feb 11, 2022

BUY
$0.95 - $1.72 $79,705 - $144,308
83,900 Added 8.52%
1,069,000 $1.02 Million
Q3 2021

Nov 12, 2021

BUY
$1.68 - $2.88 $983,136 - $1.69 Million
585,200 Added 146.34%
985,100 $1.67 Million
Q2 2021

Aug 13, 2021

BUY
$1.88 - $3.56 $751,812 - $1.42 Million
399,900 New
399,900 $1.12 Million
Q1 2021

May 13, 2021

SELL
$1.47 - $3.29 $467,989 - $1.05 Million
-318,360 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$1.36 - $1.75 $124,245 - $159,874
91,357 Added 40.24%
318,360 $462,000
Q3 2020

Nov 13, 2020

SELL
$1.5 - $2.2 $138,921 - $203,750
-92,614 Reduced 28.98%
227,003 $341,000
Q2 2020

Aug 13, 2020

BUY
$1.69 - $2.79 $143,516 - $236,929
84,921 Added 36.18%
319,617 $662,000
Q1 2020

May 14, 2020

BUY
$1.59 - $3.35 $183,797 - $387,246
115,596 Added 97.06%
234,696 $446,000
Q4 2019

Feb 13, 2020

BUY
$2.68 - $4.85 $319,188 - $577,635
119,100 New
119,100 $343,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $259M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.